Abstract
Mental illnesses are affecting several millions of individuals in the U.S and worldwide. Statistics have revealed that one among six adults in the United States is suffering from a mental illness with varying severity. Accordingly, mental illnesses are considered as one of the major factors behind the global disability as well as health and economic burden. The conventional treatments prescribed to treat mood and mental disorders are observed to show a response in only 30-40% of patients with major depression disorder (MDD). Besides, the serious adverse events associated with these treatments have also made it urgent for scientists and researchers to search for other alternatives to be used as monotherapies or adjuvants to conventional treatments. In this review, we have summarized a number of the most extensively-studied natural remedies indicated for the treatment of anxiety and depression. We have also included some of the common nutraceuticals used to treat both anxiety and depression, along with a number of the newly-emerged adjuvant therapies.
Keywords: Herbal medicine, Nutraceuticals, Anxiety, Depression, Adjuvant therapy, Mental illness.
Graphical Abstract
Current Psychopharmacology
Title:Herbal Medication and Nutraceuticals for the Management of Anxiety and Depression
Volume: 7
Author(s): Sara Nidal Abed, Fatimah Amin Younes, Hiba Salim Surchi and Pran Kishore Deb*
Affiliation:
- Faculty of Pharmacy, Philadelphia University-19392, Amman,Jordan
Keywords: Herbal medicine, Nutraceuticals, Anxiety, Depression, Adjuvant therapy, Mental illness.
Abstract: Mental illnesses are affecting several millions of individuals in the U.S and worldwide. Statistics have revealed that one among six adults in the United States is suffering from a mental illness with varying severity. Accordingly, mental illnesses are considered as one of the major factors behind the global disability as well as health and economic burden. The conventional treatments prescribed to treat mood and mental disorders are observed to show a response in only 30-40% of patients with major depression disorder (MDD). Besides, the serious adverse events associated with these treatments have also made it urgent for scientists and researchers to search for other alternatives to be used as monotherapies or adjuvants to conventional treatments. In this review, we have summarized a number of the most extensively-studied natural remedies indicated for the treatment of anxiety and depression. We have also included some of the common nutraceuticals used to treat both anxiety and depression, along with a number of the newly-emerged adjuvant therapies.
Export Options
About this article
Cite this article as:
Abed Sara Nidal , Younes Fatimah Amin , Surchi Hiba Salim and Deb Kishore Pran *, Herbal Medication and Nutraceuticals for the Management of Anxiety and Depression, Current Psychopharmacology 2018; 7 (2) . https://dx.doi.org/10.2174/2211556007666180706155506
DOI https://dx.doi.org/10.2174/2211556007666180706155506 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Method for Precise Extraction of EEG Rhythmic Activities Using Multivariate Empirical Mode Decomposition and the Hilbert Transform
Neuroscience and Biomedical Engineering (Discontinued) Involvement of Potassium and Chloride Channels and Other Transporters in Volume Regulation by Spermatozoa
Current Pharmaceutical Design Antidepressant Use in Children and Adolescents Diagnosed with Major Depressive Disorder: What Can We Learn from Published Data?
Reviews on Recent Clinical Trials Molecular Interaction of Human Brain Acetylcholinesterase with a Natural Inhibitor Huperzine-B: An Enzoinformatics Approach
CNS & Neurological Disorders - Drug Targets Anti-Tumor Vaccines in Head and Neck Cancer: Targeting Immune Responses to the Tumor
Current Cancer Drug Targets Medicinal Plants for the Treatment of Hair Loss and the Suggested Mechanisms
Current Pharmaceutical Design Anti-cancer Potential of Phyto-alkaloids: A Prospective Review
Current Cancer Therapy Reviews Change in INSR, APBA2 and IDE Gene Expressions in Brains of Alzheimer's Disease Patients
Current Alzheimer Research Mechanism of Drug and Toxic Actions of Gossypol: Focus on Reactive Oxygen Species and Electron Transfer
Current Medicinal Chemistry Editorial [Hot Topic: Latest Developments in the Treatment of Inflammatory Disease (Guest Editor: David Fairlie)]
Current Medicinal Chemistry COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods
Anti-Cancer Agents in Medicinal Chemistry Biological and Psychological Mechanisms of Seasonal Affective Disorder: A Review and Integration
Current Psychiatry Reviews Erythropoietin Employs Cell Longevity Pathways of SIRT1 to Foster Endothelial Vascular Integrity During Oxidant Stress
Current Neurovascular Research Review and Analysis of thought Records: Creating a Coding System
Current Psychiatry Research and Reviews Current Therapeutic Leads for the Treatment of Melanoma: Targeted Immunotherapy in the Post-genomic Era
Current Molecular Pharmacology Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period
Recent Patents on Anti-Infective Drug Discovery The Critical Role of the Endocannabinoid System in Emotional Homeostasis: Avoiding Excess and Deficiencies
Mini-Reviews in Medicinal Chemistry Meet Our Editorial Board Member:
Current Neuropharmacology Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-Activity Relationship Studies
Current Drug Targets Recent Advances of Sulfonylation Reactions in Water
Current Organic Synthesis